• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国三阴性乳腺癌的临床病理特征及预后:一项针对35岁以下患者的回顾性队列研究

Clinicopathologic features and prognosis of triple-negative breast cancer in China: a retrospective cohort study of patients under 35 years old.

作者信息

Li Hao, He Zhongnan, Yang Qianwen, Wang Jiaming, Ling Yan

机构信息

Department of General Surgery, The First People's Hospital of Anqing Anqing, Anhui, China.

Department of Thyroid and Breast Surgery, Hezhou People's Hospital Hezhou, Guangxi, China.

出版信息

Int J Clin Exp Pathol. 2021 Jan 1;14(1):24-33. eCollection 2021.

PMID:33532020
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7847486/
Abstract

AIM

To analyze factors that affect the prognosis of triple-negative breast cancer patients under 35 years old.

MATERIAL AND METHODS

We retrospectively analyzed confirmed triple-negative breast cancer cases from 2000 to 2016 in multiple institutions. A total of 105 patients were included in the study, Nineteen of them were diagnosed with age ≤ 25, and 86 of them were aged between 26 to 35.

RESULT

There were no statistically significant differences in clinicopathologic features and treatment choices between patients aged ≤ 25 years and those aged 26-35 years (P > 0.05). Survival analysis showed no statistically significant differences in DFS and OS between the two groups (P > 0.05). Multiple factor analysis showed that age of menarche (HR 0.697, 95% CI [0.5634, 0.8631]), pregnancy correlation (HR 2.673, 95% CI [1.1581, 6.1741]), and lymph node positivity (HR 4.915, 95% CI [2.3774, 10.1627]) were independent prognostic factors that affected patients' DFS. Independent prognostic factors that influenced OS were age of menarche (HR 0.598, 95% CI [0.462 6, 0.775]) and lymph node positivity (HR 7.751, 95% CI [2.923, 20.559]).

CONCLUSION

There was no difference in the clinicopathological features and prognosis between women ≤ 25 and women aged 26-35 years with triple-negative breast cancer. Age of menarche, pregnancy correlation, and positive lymph nodes were independent factors affecting prognosis. The relationship between reproductive factors and prognosis in young patients with triple-negative breast cancer needs further discussion.

摘要

目的

分析影响35岁以下三阴性乳腺癌患者预后的因素。

材料与方法

我们回顾性分析了2000年至2016年多家机构确诊的三阴性乳腺癌病例。本研究共纳入105例患者,其中19例诊断时年龄≤25岁,86例年龄在26至35岁之间。

结果

年龄≤25岁的患者与年龄在26 - 35岁的患者在临床病理特征和治疗选择上无统计学显著差异(P>0.05)。生存分析显示两组间无病生存期(DFS)和总生存期(OS)无统计学显著差异(P>0.05)。多因素分析显示,初潮年龄(HR 0.697,95%可信区间[0.5634, 0.8631])、妊娠相关性(HR 2.673,95%可信区间[1.1581, 6.1741])和淋巴结阳性(HR 4.915,95%可信区间[2.3774, 10.1627])是影响患者DFS的独立预后因素。影响OS的独立预后因素是初潮年龄(HR 0.598,95%可信区间[0.462 6, 0.775])和淋巴结阳性(HR 7.751,95%可信区间[2.923, 20.559])。

结论

年龄≤25岁的三阴性乳腺癌女性与年龄在26 - 35岁的女性在临床病理特征和预后方面无差异。初潮年龄、妊娠相关性和淋巴结阳性是影响预后的独立因素。年轻三阴性乳腺癌患者生殖因素与预后的关系有待进一步探讨。

相似文献

1
Clinicopathologic features and prognosis of triple-negative breast cancer in China: a retrospective cohort study of patients under 35 years old.中国三阴性乳腺癌的临床病理特征及预后:一项针对35岁以下患者的回顾性队列研究
Int J Clin Exp Pathol. 2021 Jan 1;14(1):24-33. eCollection 2021.
2
[Evaluation of the predictive effect of PD-L1 expression on survival in early triple-negative breast cancer].[PD-L1表达对早期三阴性乳腺癌生存的预测作用评估]
Zhonghua Zhong Liu Za Zhi. 2023 Nov 23;45(11):948-954. doi: 10.3760/cma.j.cn112152-20210630-00486.
3
[The influence of molecular classification of breast cancer on the safety of breast-conserving surgery].[乳腺癌分子分类对保乳手术安全性的影响]
Zhonghua Zhong Liu Za Zhi. 2018 May 23;40(5):341-346. doi: 10.3760/cma.j.issn.0253-3766.2018.05.005.
4
Outcomes of locally advanced breast cancer patients with ≥ 10 positive axillary lymph nodes.≥10 个阳性腋窝淋巴结的局部晚期乳腺癌患者的结局。
Med Oncol. 2013;30(3):615. doi: 10.1007/s12032-013-0615-7. Epub 2013 Jun 1.
5
Additional Prognostic Value of Lymph Node Ratio (LNR) and Number of Negative Lymph Nodes (NLNs) in Chinese Patients with Triple Negative Breast Cancer.淋巴结比率(LNR)和阴性淋巴结数量(NLNs)对中国三阴性乳腺癌患者的额外预后价值
Ann Clin Lab Sci. 2017 Jan;47(1):68-75.
6
Clinicopathological characteristics and prognosis of metaplastic breast cancer versus triple-negative invasive ductal carcinoma: a retrospective analysis.化生性乳腺癌与三阴性浸润性导管癌的临床病理特征和预后比较:一项回顾性分析。
World J Surg Oncol. 2023 Nov 24;21(1):364. doi: 10.1186/s12957-023-03261-w.
7
Axillary lymph node micrometastases decrease triple-negative early breast cancer survival.腋窝淋巴结微转移会降低三阴性早期乳腺癌患者的生存率。
Br J Cancer. 2016 Oct 25;115(9):1024-1031. doi: 10.1038/bjc.2016.283. Epub 2016 Sep 29.
8
[Long-term recurrence rate and survival in different aged patients with breast cancer undergoing breast conserving therapy].[不同年龄乳腺癌患者保乳治疗后的长期复发率及生存率]
Zhonghua Wai Ke Za Zhi. 2021 Feb 1;59(2):127-133. doi: 10.3760/cma.j.cn112139-20200807-00617.
9
A prognostic model for triple-negative breast cancer patients based on node status, cathepsin-D and Ki-67 index.基于淋巴结状态、组织蛋白酶-D和Ki-67指数的三阴性乳腺癌患者预后模型。
PLoS One. 2013 Dec 10;8(12):e83081. doi: 10.1371/journal.pone.0083081. eCollection 2013.
10
Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer.三阴性乳腺癌与非三阴性乳腺癌的临床病理特征及预后比较
J Cancer. 2016 Jan 1;7(2):167-73. doi: 10.7150/jca.10944. eCollection 2016.

引用本文的文献

1
Optimal response to tislelizumab plus chemotherapy in metastatic triple-negative breast cancer: a case report and literature review.替雷利珠单抗联合化疗治疗转移性三阴性乳腺癌的最佳反应:病例报告及文献综述
Front Oncol. 2024 Mar 28;14:1328844. doi: 10.3389/fonc.2024.1328844. eCollection 2024.
2
Value of Histogram of Gray-Scale Ultrasound Image in Differential Diagnosis of Small Triple Negative Breast Invasive Ductal Carcinoma and Fibroadenoma.灰度超声图像直方图在三阴性乳腺浸润性导管癌与纤维瘤鉴别诊断中的价值
Cancer Manag Res. 2022 Apr 21;14:1515-1524. doi: 10.2147/CMAR.S359986. eCollection 2022.

本文引用的文献

1
Triple negative breast cancer: A thorough review of biomarkers.三阴性乳腺癌:生物标志物的全面综述。
Crit Rev Oncol Hematol. 2020 Jan;145:102855. doi: 10.1016/j.critrevonc.2019.102855. Epub 2019 Dec 20.
2
Exploring specific prognostic biomarkers in triple-negative breast cancer.探索三阴性乳腺癌中的特定预后生物标志物。
Cell Death Dis. 2019 Oct 24;10(11):807. doi: 10.1038/s41419-019-2043-x.
3
Relationships between Reproductive Risk Factors for Breast Cancer and Tumor Molecular Subtypes.乳腺癌生殖风险因素与肿瘤分子亚型之间的关系。
Asian Pac J Cancer Prev. 2018 Jul 27;19(7):1767-1770. doi: 10.22034/APJCP.2018.19.7.1767.
4
[The influence of molecular classification of breast cancer on the safety of breast-conserving surgery].[乳腺癌分子分类对保乳手术安全性的影响]
Zhonghua Zhong Liu Za Zhi. 2018 May 23;40(5):341-346. doi: 10.3760/cma.j.issn.0253-3766.2018.05.005.
5
Eighth Edition of the AJCC Cancer Staging Manual: Breast Cancer.《美国癌症联合委员会(AJCC)癌症分期手册》第八版:乳腺癌
Ann Surg Oncol. 2018 Jul;25(7):1783-1785. doi: 10.1245/s10434-018-6486-6. Epub 2018 Apr 18.
6
Tumor characteristics and prognosis in women with pregnancy-associated breast cancer.妊娠相关性乳腺癌的肿瘤特征和预后。
Int J Cancer. 2018 Apr 1;142(7):1343-1354. doi: 10.1002/ijc.31174. Epub 2017 Dec 4.
7
A Prognostic Model for Patients with Triple-Negative Breast Cancer: Importance of the Modified Nottingham Prognostic Index and Age.三阴性乳腺癌患者的预后模型:改良诺丁汉预后指数和年龄的重要性。
J Breast Cancer. 2017 Mar;20(1):65-73. doi: 10.4048/jbc.2017.20.1.65. Epub 2017 Mar 24.
8
Evaluation of Local and Distant Recurrence Patterns in Patients with Triple-Negative Breast Cancer According to Age.根据年龄评估三阴性乳腺癌患者的局部和远处复发模式
Ann Surg Oncol. 2017 Mar;24(3):698-704. doi: 10.1245/s10434-016-5631-3. Epub 2016 Oct 25.
9
Tumor subtype-specific associations of hormone-related reproductive factors on breast cancer survival.激素相关生殖因素与乳腺癌生存的肿瘤亚型特异性关联
PLoS One. 2015 Apr 14;10(4):e0123994. doi: 10.1371/journal.pone.0123994. eCollection 2015.
10
Contribution of personalized Cyclin D1 genotype to triple negative breast cancer risk.个性化细胞周期蛋白D1基因型对三阴性乳腺癌风险的影响
Biomedicine (Taipei). 2014;4(1):3. doi: 10.7603/s40681-014-0003-4. Epub 2014 Aug 27.